Shares
ASX-listed biotech Neuren awaiting lucrative FDA approval
Our hot stock of the week, Neuren Pharmaceuticals, could soon be one of a handful of ASX-listed companies with an FDA-approved drug.
Why lithium stocks are falling despite surging demand for EVs
The demand for electric vehicles is outstripping supply, yet lithium stocks have continued to fall. Does this spell opportunity for investors?
Friends With Money #52: Starting with shares
Is now the time to start buying shares or is the market too volatile? Roger Kinsky joins us on the Friends With Money podcast.
More pain ahead: What’s next for the Australian stock market
The Australian stock market has continued to fall this week and is currently down more than 5%, with further falls looking likely.
Should you buy, hold or sell shares in Endeavour Group?
Endeavour Group boasts brands including Dan Murphy's and BWS, so how has the company performed since spinning off from Woolworths last June?
Here’s what happened to shares the last time the RBA raised rates
With uncertain times ahead after two interest rate hikes in as many months, we look back at the last time the country saw consecutive cash rate increases.
Should you sell your underperforming assets by June 30?
Have your shares or ETFs fallen in value since you bought them? Selling them now at a loss could pay off for you at tax time.
Auckland International Airport to take off
International travel was hammered by COVID-19, but are Auckland International Airport shares shaping up in the face of the reopening?
Market wrap: Is the tech bubble bursting again?
By mid-May, the Australian tech sector had effectively fallen back to pre-COVID levels and taken with it the hopes of many investors.
Should you buy, hold or sell Nine Entertainment shares?
If Nine successfully makes the transition to serving people the entertainment they want in the way they want it, there is every chance it could become a hit investment.
